Sunshine Biopharma Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sunshine Biopharma Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Sunshine Biopharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $541K, a 18.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $541K -$123K -18.5% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $564K -$147K -20.7% Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 $600K -$128K -17.6% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $647K -$114K -14.9% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $664K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $711K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $728K Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $760K +$760K Dec 31, 2022 10-K 2024-03-28
Q4 2021 $0 Dec 31, 2021 10-K 2023-04-04
Q1 2019 $95.6K Mar 31, 2019 10-Q 2019-05-20
Q4 2018 $0 Dec 31, 2018 10-Q 2019-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.